ES2184880T3 - Asociacion hormonal estrogeno-progestageno, su procedimiento de preparacion y su utilizacion en medicamentos. - Google Patents

Asociacion hormonal estrogeno-progestageno, su procedimiento de preparacion y su utilizacion en medicamentos.

Info

Publication number
ES2184880T3
ES2184880T3 ES96923018T ES96923018T ES2184880T3 ES 2184880 T3 ES2184880 T3 ES 2184880T3 ES 96923018 T ES96923018 T ES 96923018T ES 96923018 T ES96923018 T ES 96923018T ES 2184880 T3 ES2184880 T3 ES 2184880T3
Authority
ES
Spain
Prior art keywords
hormonal
association
estrogeno
progestagen
medicines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96923018T
Other languages
English (en)
Inventor
Michel Lanquetin
Jacques Paris
Jean-Louis Thomas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoire Theramex SAM
Original Assignee
Laboratoire Theramex SAM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9481610&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2184880(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Laboratoire Theramex SAM filed Critical Laboratoire Theramex SAM
Application granted granted Critical
Publication of ES2184880T3 publication Critical patent/ES2184880T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE AL CAMPO DE LA QUIMICA TERAPEUTICA. SE REFIERE MAS PRECISAMENTE A UNA ASOCIACION HORMONAL, ESTROPROGESTOGENA, TRISECUENCIAL CARACTERIZADA PORQUE ESTA CONSTITUIDA POR UNIDADES DE DOSIFICACION QUE NO CONTIENEN MAS QUE UN ESTROGENO, UNIDADES DE DOSIFICACION QUE CONTIENEN UNA COMBINACION DE UN ESTROGENO Y DE UN PREOGESTOGENO Y UNIDADES QUE NO CONTIENEN MAS QUE UN EXCIPIENTE. ESTE MODO DE ADMINISTRACION TRISENCUENCIAL SE DESTINA A COMPENSAR LOS TRASTORNOS FUNCIONALES ARRASTRADOS POR UNA HIPOESTROGENIA ASOCIADA A LA MENOPAUSIA O A LA PREMENOPAUSIA.
ES96923018T 1995-08-01 1996-07-29 Asociacion hormonal estrogeno-progestageno, su procedimiento de preparacion y su utilizacion en medicamentos. Expired - Lifetime ES2184880T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9509364A FR2737411B1 (fr) 1995-08-01 1995-08-01 Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques

Publications (1)

Publication Number Publication Date
ES2184880T3 true ES2184880T3 (es) 2003-04-16

Family

ID=9481610

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96923018T Expired - Lifetime ES2184880T3 (es) 1995-08-01 1996-07-29 Asociacion hormonal estrogeno-progestageno, su procedimiento de preparacion y su utilizacion en medicamentos.

Country Status (30)

Country Link
US (1) US5891867A (es)
EP (1) EP0783310B1 (es)
JP (1) JPH10507207A (es)
KR (1) KR100450649B1 (es)
CN (1) CN1138547C (es)
AP (1) AP829A (es)
AR (1) AR004502A1 (es)
AT (1) ATE225659T1 (es)
AU (1) AU722355B2 (es)
BR (1) BR9606549A (es)
CA (1) CA2201368C (es)
CZ (1) CZ289706B6 (es)
DE (1) DE69624214T2 (es)
DK (1) DK0783310T3 (es)
DZ (1) DZ2078A1 (es)
ES (1) ES2184880T3 (es)
FR (1) FR2737411B1 (es)
HU (1) HU229843B1 (es)
IL (1) IL120558A (es)
MA (1) MA23946A1 (es)
MX (1) MX9702381A (es)
MY (1) MY117307A (es)
NO (1) NO312996B1 (es)
OA (1) OA10411A (es)
PT (1) PT783310E (es)
RU (1) RU2188641C2 (es)
TN (1) TNSN96101A1 (es)
TW (1) TW473390B (es)
WO (1) WO1997004784A1 (es)
ZA (1) ZA966545B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2754179B1 (fr) * 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
WO2001030355A1 (fr) * 1999-10-25 2001-05-03 Laboratoire Theramex Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation
US6787531B1 (en) * 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
WO2001030356A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
US20020132801A1 (en) * 2001-01-11 2002-09-19 Schering Aktiengesellschaft Drospirenone for hormone replacement therapy
FR2814074B1 (fr) * 2000-09-15 2003-03-07 Theramex Nouvelles compositions estro-progestatives topiques a effet systemique
US20020151732A1 (en) * 2001-01-05 2002-10-17 Claes Ohlsson Estrogen receptors
US20030004145A1 (en) * 2001-05-16 2003-01-02 Leonard Thomas W. Treatment of conditions relating to hormone deficiencies by administration of progestins
EP2305230B1 (en) * 2001-12-05 2015-11-04 Teva Women's Health, Inc. Oral contraceptives to prevent pregnancy
US7008979B2 (en) * 2002-04-30 2006-03-07 Hydromer, Inc. Coating composition for multiple hydrophilic applications
JP2007534622A (ja) * 2003-07-16 2007-11-29 デュラメド ファーマシューティカルズ インコーポレーティッド 連続的エストロゲン投与での避妊薬療法を利用するホルモン処置の方法
US20070111975A1 (en) 2004-10-07 2007-05-17 Duramed Pharmaceuticals, Inc. Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
US8022053B2 (en) * 2004-11-02 2011-09-20 Bayer Schering Pharma Aktiengesellschaft Oral solid dosage forms containing a low dose of estradiol
AR065816A1 (es) * 2007-03-26 2009-07-01 Theramex Regimen anticonceptivo oral

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4390531A (en) * 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
US4870066A (en) * 1986-08-11 1989-09-26 The University Of Kentucky Research Foundation Method and composition for safely delaying parturition and synchronizing farrowing in swine
DE69132061D1 (de) * 1990-09-28 2000-04-20 I F L O S A S Di Giorgio E Ald Kontrazeptives und Menstruationszyklus regulierendes Präparat mit onkostatischen Eigenschaften
FR2695826B1 (fr) * 1992-09-21 1995-01-06 Theramex Nouvelles compositions pharmaceutiques à base de dérivés de nomégestrol et leurs procédés d'obtention.

Also Published As

Publication number Publication date
AP9700979A0 (en) 1997-07-31
AR004502A1 (es) 1998-12-16
CZ96797A3 (cs) 1998-08-12
FR2737411A1 (fr) 1997-02-07
IL120558A0 (en) 1997-07-13
MA23946A1 (fr) 1997-04-01
KR970706004A (ko) 1997-11-03
NO971449D0 (no) 1997-03-26
DZ2078A1 (fr) 2002-10-22
DE69624214T2 (de) 2003-07-10
HUP9900612A2 (hu) 1999-07-28
DK0783310T3 (da) 2003-02-10
PT783310E (pt) 2003-02-28
RU2188641C2 (ru) 2002-09-10
DE69624214D1 (de) 2002-11-14
HUP9900612A3 (en) 1999-11-29
HU229843B1 (en) 2014-09-29
MX9702381A (es) 1998-02-28
AU722355B2 (en) 2000-07-27
IL120558A (en) 2002-09-12
CA2201368A1 (fr) 1997-02-13
CN1167438A (zh) 1997-12-10
EP0783310A1 (fr) 1997-07-16
AP829A (en) 2000-05-03
TW473390B (en) 2002-01-21
US5891867A (en) 1999-04-06
NO971449L (no) 1997-05-30
MY117307A (en) 2004-06-30
CZ289706B6 (cs) 2002-03-13
ZA966545B (en) 1997-05-08
NO312996B1 (no) 2002-07-29
CN1138547C (zh) 2004-02-18
HK1005227A1 (en) 1998-12-31
BR9606549A (pt) 1998-06-23
TNSN96101A1 (fr) 2005-03-15
KR100450649B1 (ko) 2004-11-16
ATE225659T1 (de) 2002-10-15
EP0783310B1 (fr) 2002-10-09
CA2201368C (fr) 2010-12-07
OA10411A (fr) 2001-12-06
FR2737411B1 (fr) 1997-10-17
JPH10507207A (ja) 1998-07-14
WO1997004784A1 (fr) 1997-02-13
AU6367496A (en) 1997-02-26

Similar Documents

Publication Publication Date Title
ES2184880T3 (es) Asociacion hormonal estrogeno-progestageno, su procedimiento de preparacion y su utilizacion en medicamentos.
ES2139132T3 (es) Composiciones farmaceuticas activas en la terapia de desordenes del sueño.
MX9301929A (es) Derivados de pirimidina y procedimientos para su preparacion.
DE69906518D1 (de) Arzneistoff-abgabesystem enthaltend eine festgepackte, feste arzneistoffbasis
ES2171746T3 (es) Empleo de epinastina para el tratamiento de dolores.
ES2187822T3 (es) Comprimidos de disgregacion rapida.
AR004700A1 (es) 1alfa, 26 dihidroxi-d-homo-vitamina d3, una composicion farmaceutica que la comprende, un procedimiento para su preparacion y el uso de los mismos en laelaboracion de un medicamento
ES2172654T3 (es) Uso de nsaid para el tratamiento de carcinomas de celulas escamosas de la cavidad oral u orofaringe.
NO20003546L (no) Anvendelse av progestin og en farmasøytisk sammensetning samt et kit inneholdende disse
UY26977A1 (es) Compuestos de imidazol condensado con arilo o heteroarilo como agentes anti-inflamatorios y analgésicos
AR015349A1 (es) Nuevas modificaciones cristalinas del 2-amino-4-(4-fluorbencilamino)-1-etoxicarbonil-aminobenceno y procedimiento para prepararlos, utilizacion de losmismas y medicamento que las contienen
ES2233931T3 (es) Fenilacetato y derivados, solos o en combinacion con otros compuestos, contra estados neoplasicos y otros trastornos.
AR026610A1 (es) Un derivado pirrolidinacetamida solo o en combinacion para tratamiento de desordenes del sistema nervioso central
ES2182161T3 (es) Utilizacion de derivados de pirimidina para la preparacion de un medicamento para la prevencion del cancer.
DE69404116D1 (de) Mit Zucker überzogene pharmazeutische Dosierungseinheit
ES2038650T3 (es) Procedimiento para preparar una composicion farmaceutica que comprende 3'-desoxitimidin-2'-eno-(3'-desoxi-2',3'-dideshidrotimidina) para tratar pacientes infectados con retrovirus.
BR9902808A (pt) Compostos, composição farmacêutica, composição cosmética e uso de uma composição cosmética
ES2184145T3 (es) Compuestos de acido sulfonico o sulfonilamino-n-(heteroaralquil)-azaheterociclilamida.
ES2119748T3 (es) Composicion farmaceutica que contiene un farmaco ligeramente soluble en agua.
DK1502586T3 (da) Anvendelse af desinficerende midler ved fremstillingen af en farmaceutisk sammensætning til forebyggelsen eller behandlingen af inflammationer i det indre af menneskekroppen
ES2129112T3 (es) Compuestos aromaticos policiclicos, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
CO4940448A1 (es) Modificacion a cristal de una sustancia de medicamento
MX9304503A (es) Compuestos antiinflamatorios.
DE59914183D1 (de) Abgabeeinrichtung für eine zusammensetzung einer pharmazeutisch wirksamen substanz
MX9300558A (es) Nueva sulfonilurea, procedimiento para su preparacion y formulado farmaceutico que la contiene.